Aeterna Zentaris Inc. (TSE:AEZS) has released an update.
Aeterna Zentaris Inc. has announced the commencement of a share consolidation approved by shareholders, which will reduce its common shares from around 4.85 million to approximately 1.21 million. This move comes alongside a merger with Ceapro Inc., with new post-consolidation shares to begin trading in early May 2024. The consolidation aims to streamline the company’s share structure and is part of a larger effort to focus on addressing unmet medical needs through its biopharmaceutical developments.
For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.
